Biography: Abbas Mandviwala, MD
Titles
- Assistant Professor, CWRU School of Medicine
Certifications & Memberships
- Internal Medicine - American Board of Internal Medicine
Education
Residency | Internal Medicine
Internal Medicine - UH Cleveland Medical Center (2016 - 2019)
Medical Education
University Of Kentucky College Of Medicine (2012 - 2016)
Undergraduate
University Of Kentucky (2007 - 2011)
About
Abbas Mandviwala, MD is an oncology hospitalist at University Hospitals Seidman Cancer Center and an Assistant Professor of Medicine at Case Western Reserve University School of Medicine. He completed both his undergraduate studies and medical school at the University of Kentucky, as a member of the Rural Physician Leadership Program.
He joined the UH/Case Western Reserve University Internal Medicine Residency Program in 2016 as a resident in the Leadership in Medical Education pathway. After graduating in 2019, Dr. Mandviwala joined as faculty at Northwestern Feinberg School of Medicine, serving as a Clinical Instructor of Medicine, before returning to Cleveland in 2020. He now serves as Director of the Internal Medicine Acting Internship Program along with a variety of other academic and entrepreneurial roles.
Dr. Mandviwala’s academic interests include modernizing medical education, POCUS, and student/resident wellness. He grew up in Kentucky, and is a die-hard UK college basketball and Los Angeles Lakers fan. In his free time he enjoys planning social events, playing basketball/golf, and spending time with family and friends.
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Abbas Mandviwala did not disclose any Outside Relationships with Industry.